Literature DB >> 15280185

Decisions and outcomes of genetic testing for inherited breast cancer risk.

C H Halbert1.   

Abstract

Since the discovery of breast cancer susceptibility genes and the availability of genetic testing, a substantial amount of research has been conducted to evaluate rates of genetic test acceptance and to understand the psychological and behavioral impact of BRCA1 and BRCA2 (BRCA1/2) genetic test results. This article explores findings related to genetic test acceptance for inherited breast cancer risk and the impact of genetic test results on psychological functioning, cancer prevention and control behaviors, and family communication about genetic testing. Overall, rates of genetic test acceptance were lower than anticipated based on interest in genetic testing reported in early research. While there is limited evidence that genetic testing generates adverse psychological effects, receiving positive BRCA1/2 test results may cause emotional reactions and concerns that are specific to such results. Although early reports suggested that receiving positive BRCA1/2 test results may have a limited impact on cancer screening or prevention behaviors, recent studies have shown that genetic testing for inherited breast cancer risk may increase screening behaviors among mutation carriers. However, utilization of some screening tests remains low among mutation carriers. Additional studies are needed to identify subgroups of participants in genetic testing who may be vulnerable to experiencing testing-specific concerns, and to evaluate the effects of interventions designed to promote behavioral change and address other concerns that may be generated by receiving positive BRCA1/2 test results. Copyright 2004 European Society for Medical Oncology

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15280185     DOI: 10.1093/annonc/mdh655

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  5 in total

1.  Comparison between CaGene 5.1 and 6.0 for BRCA1/2 mutation prediction: a retrospective study of 150 BRCA1/2 genetic tests in 517 families with breast/ovarian cancer.

Authors:  Ivana Antonucci; Martina Provenzano; Luca Sorino; Michela Balsamo; Gitana Maria Aceto; Pasquale Battista; David Euhus; Ettore Cianchetti; Patrizia Ballerini; Clara Natoli; Giandomenico Palka; Liborio Stuppia
Journal:  J Hum Genet       Date:  2016-12-08       Impact factor: 3.172

2.  Efficient computation of the joint probability of multiple inherited risk alleles from pedigree data.

Authors:  Thomas Madsen; Danielle Braun; Gang Peng; Giovanni Parmigiani; Lorenzo Trippa
Journal:  Genet Epidemiol       Date:  2018-06-25       Impact factor: 2.135

3.  Interest in genetic testing for modest changes in breast cancer risk: implications for SNP testing.

Authors:  K D Graves; B N Peshkin; G Luta; W Tuong; M D Schwartz
Journal:  Public Health Genomics       Date:  2011-04-02       Impact factor: 2.000

4.  The effect of referral for genetic counseling on genetic testing and surgical prevention in women at high risk for ovarian cancer: Results from a randomized controlled trial.

Authors:  Charles W Drescher; J David Beatty; Robert Resta; M Robyn Andersen; Kate Watabayashi; Jason Thorpe; Sarah Hawley; Hannah Purkey; Jessica Chubak; Nancy Hanson; Diana S M Buist; Nicole Urban
Journal:  Cancer       Date:  2016-07-22       Impact factor: 6.860

5.  Adult daughters' reports of breast cancer risk reduction and early detection advice received from their mothers: an exploratory study.

Authors:  Pamela S Sinicrope; Christi A Patten; Lara P Clark; Tabetha A Brockman; Emily E Rock; Marlene H Frost; Larra R Petersen; Robert A Vierkant; Celine M Vachon; Zachary S Fredericksen; Carol A Janney; Thomas A Sellers; James R Cerhan
Journal:  Psychooncology       Date:  2009-02       Impact factor: 3.894

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.